<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="prelim-section" /><meta name="keywords" content="Adverse reactions, reporting; Yellow cards: adverse drug reporting; Black triangle symbol" /><meta name="IX" content="Adverse reactions, reporting; Yellow cards: adverse drug reporting; Black triangle symbol" /><title>Adverse reactions to drugs: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="29432.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="29432.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=29432.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="29403.htm">Guidance on prescribing</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="129783.htm" title="Previous: Prescribing of diamorphine (heroin), dipipanone, and cocaine for addicts">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="29436.htm" title="Next: Special problems">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>BNF for Children</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/29432.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Adverse reactions to drugs</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; General guidance</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_29432">Adverse reactions to drugs</h1><?highlighter on?><div id="pC" class="jN"><p>Any drug may produce unwanted or unexpected adverse reactions.
Rapid detection and recording of adverse drug reactions is of vital
importance so that unrecognised hazards are identified promptly and
appropriate regulatory action is taken to ensure that medicines are
used safely. Healthcare professionals and coroners (see also Self-reporting
below) are urged to report suspected adverse drug reactions directly to
the Medicines and Healthcare products Regulatory Agency (MHRA) through
the Yellow
Card Scheme using the electronic form at <a href="http://www.yellowcard.gov.uk" title="external link">www.yellowcard.gov.uk</a>. Alternatively, prepaid Yellow Cards for reporting are available
from the address below and are also bound in  the inside back cover of the <i>BNF</i>.</p><p>Send Yellow Cards to:</p><address>FREEPOST YELLOW CARD<br />(No other address details required)<br /></address><div class="cBA"><div>
      Tel:
      0800 731 6789</div></div><p>Suspected adverse drug reactions to <i>any</i> therapeutic
agent should be reported, including drugs <i>(self-medication</i> as well as those <i>prescribed)</i>, blood products, vaccines,
radiographic contrast media, complementary and herbal products.</p><p>A 24-hour Freephone service is available to all parts of the
UK for advice and information on suspected adverse drug reactions;
contact the National Yellow Card Information Service at the MHRA on
0800 731 6789. Outside office hours a telephone-answering machine
will take messages.</p><p>The following Yellow Card Centres can be contacted for further
information: </p><address>Yellow Card Centre Northwest<br />2nd Floor<br />70 Pembroke Place<br />Liverpool<br />L69 3GF<br /></address><div class="cBA"><div>
      Tel:
      (0151) 794 8122</div></div><address>Yellow Card Centre Wales<br />Cardiff University<br />Department of Pharmacology, Therapeutics and Toxicology<br />Heath Park<br />Cardiff<br />CF14 4XN<br /></address><div class="cBA"><div>
      Tel:
      (029) 2074 4181</div></div><address>Yellow Card Centre Northern &amp; Yorkshire<br />Wolfson Unit<br />Claremont Place<br />Newcastle upon Tyne<br />NE2 4HH<br /></address><div class="cBA"><div>
      Tel:
      (0191) 260 6181</div></div><address>Yellow Card Centre West Midlands<br />City Hospital<br />Dudley Road<br />Birmingham<br />B18 7QH<br /></address><div class="cBA"><div>
      Tel:
      (0121) 507 5672</div></div><address>Yellow Card Centre Scotland<br />CARDS, Royal Infirmary of Edinburgh<br />51 Little France Crescent<br />Old Dalkeith Road<br />Edinburgh<br />EH16 4SA<br /></address><div class="cBA"><div>
      Tel:
      (0131) 242 2919</div></div><p>The MHRA’s database facilitates the monitoring
of adverse drug reactions.</p><p>More detailed information on reporting and a list of products
currently under intensive monitoring can be found on the MHRA website: <a href="http://medicines.mhra.gov.uk" title="external link">www.mhra.gov.uk</a>.</p><div class="cN"><h3 class="cBP">MHRA Drug Safety Update</h3><p><i>Drug Safety Update</i> is a monthly newsletter
from the MHRA and the Commission on Human Medicines (CHM); it is available
at <a href="http://www.mhra.gov.uk/drugsafetyupdate" title="external link">www.mhra.gov.uk/drugsafetyupdate</a>.</p></div><div class="cAZ"><h2>Self-reporting</h2> <p class="cAX">Patients and their carers can also
report suspected adverse drug reactions to the MHRA. Reports can be
submitted directly to the MHRA through the Yellow Card Scheme using
the electronic form at <a href="http://www.yellowcard.gov.uk" title="external link">www.yellowcard.gov.uk</a>, by telephone on 0808 100
3352, or by downloading the Yellow Card form from <a href="http://www.mhra.gov.uk" title="external link">www.mhra.gov.uk</a>. Alternatively,
patient Yellow Cards are available from pharmacies and GP surgeries.
Information for patients about the Yellow Card Scheme is available
in other languages at <a href="http://www.yellowcard.gov.uk" title="external link">www.yellowcard.gov.uk</a>.</p></div><div class="cAZ"><h2>Prescription-event monitoring</h2> <p class="cAX">In addition to the
MHRA’s Yellow Card Scheme, an independent scheme monitors the safety
of new medicines using a different approach. The Drug Safety Research
Unit identifies patients who have been prescribed selected new medicines
and collects data on clinical events in these patients. The data are
submitted on a voluntary basis by general practitioners on green forms.
 More information about the scheme and the Unit’s educational material
is available from <a href="http://www.dsru.org" title="external link">www.dsru.org</a>.</p></div><div id="_207970"><div class="cAZ"><h2>Newer drugs and vaccines</h2> <p class="cAX">Only limited information
is available from clinical trials on the safety of new medicines.
Further understanding about the safety of medicines depends on the
availability of information from routine clinical practice.</p><p>The black triangle
symbol (<a href="204285.htm" title="Report adverse reaction(s)"><img class="cK" src="images/blacktri_l.png" alt="Black triangle" /></a>) identifies newly licensed medicines that
are monitored intensively by the MHRA. Such medicines include new
active substances, biosimilar medicines, medicines that have been
licensed for administration by a new route or drug delivery system,
or for significant new indications which may alter the established
risks and benefits of that drug, or that contain a new combination
of active substances. There is no standard time for which products
retain a black triangle; safety data are usually reviewed after 2
years.</p><p>Spontaneous reporting is particularly valuable for recognising
possible new hazards rapidly. For medicines showing the black triangle
symbol, the MHRA asks that <b>all</b> suspected reactions
(including those considered not to be serious) are reported through
the Yellow Card Scheme. An adverse reaction should be reported even
if it is not certain that the drug has caused it, or if the reaction
is well recognised, or if other drugs have been given at the same
time.</p></div></div><div class="cAZ"><h2>Established drugs and vaccines</h2> <p class="cAX">Healthcare professionals
and coroners are asked to report <b>all</b> serious suspected
reactions to established drugs (including over-the-counter, herbal,
and unlicensed medicines and medicines used off-label) and vaccines.
Serious reactions include those that are fatal, life-threatening,
disabling, incapacitating, or which result in or prolong hospitalisation;
they should be reported even if the effect is well recognised. Examples
include anaphylaxis, blood disorders, endocrine disturbances, effects
on fertility, haemorrhage from any site, renal impairment, jaundice,
ophthalmic disorders, severe CNS effects, severe skin reactions, reactions
in pregnant women, and any drug interactions. Reports of serious adverse
reactions are required to enable comparison with other drugs of a
similar class. Reports of overdoses (deliberate or accidental) can
complicate the assessment of adverse drug reactions, but provide important
information on the potential toxicity of drugs.</p></div><p>For established drugs there is no need to report well-known,
relatively minor side-effects, such as dry mouth with tricyclic antidepressants
or constipation with opioids.</p><div class="cAZ"><h2>Adverse reactions to medical devices</h2> <p class="cAX">Suspected
adverse reactions to medical devices including dental or surgical
materials, intra-uterine devices, and contact lens fluids should be
reported. Information on reporting these can be found at: <a href="http://devices.mhra.gov.uk" title="external link">www.mhra.gov.uk</a>.</p></div><div class="cAZ"><h2>Side-effects in the BNF</h2> <p class="cAX">The BNF includes clinically
relevant side-effects for most drugs; an exhaustive list is not included
for drugs that are used by specialists (e.g. cytotoxic drugs and drugs
used in anaesthesia). Where causality has not been established, side-effects
in the manufacturers’ literature may be omitted from the BNF. </p><p>Recognising that hypersensitivity reactions can occur with virtually
all medicines, this effect is not generally listed, unless the drug
carries an increased risk of such reactions. The BNF also omits effects
that are likely to have little clinical consequence (e.g. transient
increase in liver enzymes).</p><p>Side-effects are generally listed in order of frequency and
arranged broadly by body systems. Occasionally a rare side-effect
might be listed first if it is considered to be particularly important
because of its seriousness.</p><p>In the product literature the frequency of side-effects is generally
described as follows:</p><table class="table" cellspacing="0" cellpadding="8" border="0" style="border-collapse: collapse;"><colgroup><col /><col /></colgroup><tbody><tr><td style=""><i>Very common</i></td><td style="">greater than 1 in 10</td></tr><tr><td style=""><i>Common</i></td><td style="">1 in 100 to 1 in 10</td></tr><tr><td style=""><i>Uncommon</i> [‘less commonly’ in BNF]</td><td style="">1 in 1000 to 1 in 100</td></tr><tr><td style=""><i>Rare</i></td><td style="">1 in 10 000 to 1 in 1000</td></tr><tr><td style=""><i>Very rare</i></td><td style="">less than 1 in 10 000</td></tr></tbody></table></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="29436.htm" title="Special problems">Special problems</a></li><li><a href="29437.htm" title="Prevention of adverse reactions">Prevention of adverse reactions</a></li><li id="_128341"><a href="128341.htm" title="Oral side-effects of drugs">Oral side-effects of drugs</a></li><li><a href="106300.htm" title="Defective medicines">Defective medicines</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="129783.htm">Previous: Prescribing of diamorphine (heroin), dipipanone, and cocaine
for addicts</a> | <a class="top" href="29432.htm#">Top</a> | <a accesskey="]" href="29436.htm">Next: Special problems</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>